These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10053213)

  • 1. The relevance of the amorphous state to pharmaceutical dosage forms: glassy drugs and freeze dried systems.
    Craig DQ; Royall PG; Kett VL; Hopton ML
    Int J Pharm; 1999 Mar; 179(2):179-207. PubMed ID: 10053213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the physical stability of freeze dried dosage forms from the glass transition temperature of the amorphous components.
    Fitzpatrick S; Saklatvala R
    J Pharm Sci; 2003 Dec; 92(12):2495-501. PubMed ID: 14603495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the physical stability of freeze-dried sucrose-containing formulations by differential scanning calorimetry.
    te Booy MP; de Ruiter RA; de Meere AL
    Pharm Res; 1992 Jan; 9(1):109-14. PubMed ID: 1589394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
    Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
    J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effective use of differential scanning calorimetry in the optimisation of freeze-drying processes and formulations.
    Hatley RH
    Dev Biol Stand; 1992; 74():105-19; discussion 119-22. PubMed ID: 1592162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical characterisation of formulations for the development of two stable freeze-dried proteins during both dried and liquid storage.
    Passot S; Fonseca F; Alarcon-Lorca M; Rolland D; Marin M
    Eur J Pharm Biopharm; 2005 Aug; 60(3):335-48. PubMed ID: 15894475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of glass transition temperatures of freeze-concentrated solutes by differential scanning calorimetry.
    Her LM; Nail SL
    Pharm Res; 1994 Jan; 11(1):54-9. PubMed ID: 8140056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of aging on the physical properties of amorphous trehalose.
    Surana R; Pyne A; Suryanarayanan R
    Pharm Res; 2004 May; 21(5):867-74. PubMed ID: 15180347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
    Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
    J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of the kinetics of protein unfolding in viscous systems and implications for protein stability in freeze-drying.
    Tang XC; Pikal MJ
    Pharm Res; 2005 Jul; 22(7):1176-85. PubMed ID: 16028019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on Stability II: stability of a vaccine.
    Abdul-Fattah AM; Truong-Le V; Yee L; Pan E; Ao Y; Kalonia DS; Pikal MJ
    Pharm Res; 2007 Apr; 24(4):715-27. PubMed ID: 17372697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermodynamic behavior of glassy state of structurally related compounds.
    Kaushal AM; Bansal AK
    Eur J Pharm Biopharm; 2008 Aug; 69(3):1067-76. PubMed ID: 18420396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the sucrose/glycine/water system by differential scanning calorimetry and freeze-drying microscopy.
    Kasraian K; Spitznagel TM; Juneau JA; Yim K
    Pharm Dev Technol; 1998 May; 3(2):233-9. PubMed ID: 9653761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sodium tetraborate and boric acid on nonisothermal mannitol crystallization in frozen solutions and freeze-dried solids.
    Izutsu K; Ocheda SO; Aoyagi N; Kojima S
    Int J Pharm; 2004 Apr; 273(1-2):85-93. PubMed ID: 15010133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calorimetry and complementary techniques to characterize frozen and freeze-dried systems.
    Sundaramurthi P; Suryanarayanan R
    Adv Drug Deliv Rev; 2012 Apr; 64(5):384-95. PubMed ID: 22210136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein stability in the amorphous carbohydrate matrix: relevance to anhydrobiosis.
    Sun WQ; Davidson P; Chan HS
    Biochim Biophys Acta; 1998 Sep; 1425(1):245-54. PubMed ID: 9813351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amorphous Sulfadoxine: A Physical Stability and Crystallization Kinetics Study.
    Aucamp M; Milne M; Liebenberg W
    AAPS PharmSciTech; 2016 Oct; 17(5):1100-9. PubMed ID: 26531745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid assessment of the structural relaxation behavior of amorphous pharmaceutical solids: effect of residual water on molecular mobility.
    Miller DP; Lechuga-Ballesteros D
    Pharm Res; 2006 Oct; 23(10):2291-305. PubMed ID: 16955371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of thermal history on the glassy state of indapamide.
    Serajuddin AT; Rosoff M; Mufson D
    J Pharm Pharmacol; 1986 Mar; 38(3):219-20. PubMed ID: 2871159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the physical stability of freeze-dried amorphous sugar matrices by compression at several hundreds MPa.
    Kagotani R; Kinugawa K; Nomura M; Imanaka H; Ishida N; Imamura K
    J Pharm Sci; 2013 Jul; 102(7):2187-97. PubMed ID: 23625861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.